Delivery Order 36C26324D0042-36C26324N0478
Award Date 2/7/24
Potential Completion Date 9/30/24
Potential Value $37K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Tonawanda, NY 14150, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Integrated Service Network 23 awarded Pine Pharmaceuticals LLC a delivery order valued at $37,715.10 on October 1, 2024, for the provision of 503B compounding pharmaceutical services. This firm fixed-price delivery order, which is set to conclude on September 30, 2025, represents work performed at Pine Pharmaceuticals' facility in Tonawanda, New York. The award falls under a larger $136,915 indefinite delivery contract that the VA awarded to Pine...
- This firm-fixed-price purchase order contract was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company located in Tonawanda, New York. The $23,753.53 contract is for the compounding of 10% Polysorbate-80 to dilute the investigational drug TPM-001 for the treatment of peritoneal cancer. The work is to be completed by May 2, 2025....
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company in Tonawanda, New York. The contract, valued at $119,062.95, is for the production of drug capsules. The award does not have a set-aside designation. Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility that specializes in pharmaceutical compounding,...
- The National Institutes of Health issued a $39,278.50 delivery order to Pine Pharmaceuticals LLC on April 21, 2026, under a total small business set-aside for oral stable isotope-deuterium oxide, with final delivery by June 1, 2026. Pine Pharmaceuticals is a small business pharmaceutical compounding and manufacturing firm. Place of performance is Tonawanda, NY. The order ceiling is $39,278.50 under firm fixed-price terms, with ultimate completion scheduled for October 30, 2026. Billing is in one...
- This is a federal delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to Pine Pharmaceuticals LLC, a for-profit limited liability company. The $158,877.60 firm fixed price contract is for the provision of metabolic isotopes, a non-severable service, with a performance period ending on April 13, 2026. Pine Pharmaceuticals is an FDA-registered 503B outsourcing...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the Department of Health and Human Services, awarded a $44,606.40 firm fixed-price purchase order to Pine Pharmaceuticals LLC, a small business contractor located in Tonawanda, New York. The contract is for the acquisition of intravenous stable isotopes, specifically D5 glycerol and 6,6 D2-glucose, to support metabolic research. This award is not associated with a larger contract vehicle. The contract has a...
- This federal contract award is for the delivery of pharmaceuticals to the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 15. The prime contractor, Pharmacy Buying Association, Inc. (doing business as PBA Health), is a for-profit organization that has been providing pharmaceuticals, medical/surgical supplies, and related services to the VA as a prime contractor since 2007. The $290,728.44 firm fixed price purchase order contract has...
- The National Institute of Diabetes and Digestive and Kidney Diseases issued a delivery order to Pine Pharmaceuticals LLC on July 8, 2026, for deuterium oxide (70%), D5 glycerol, and 6,6 deuterated glucose with a ceiling value of $410,842.56. The order is set-aside for total small business and is firm fixed price. Place of performance is Tonawanda, NY. Ultimate completion is September 30, 2026. Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility specializing in pharmaceutical...
- This federal contract award is for the provision of pharmaceuticals to the Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract was awarded to Pharmacy Buying Association, Inc., doing business as PBA Health, a small business prime contractor. The $249,389.25 firm fixed price purchase order requires PBA Health to deliver specified quantities of medications, medical devices, testing supplies, and reports by the designated completion date of July 23, 2018. This...
- This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Pharmacy Buying Association, Inc. (PBA Health), a for-profit small business organization. The contract is for the delivery of pharmaceutical products, including Angragrelide HCL, Chlorzoxazone, Estradiol 0.1 mg, and Estradiol 0.0375 mg, to VA healthcare facilities. The contract has a firm fixed-price value of $100,407.58 and an ultimate completion date of April 14, 2017. PBA Health has an existing Indefinite...